Randomised trial evaluating chemotherapy alone or chemotherapy and a novel monoclonal antibody for canine T‐cell lymphoma: A multicentre US study

BACKGROUND: Canine peripheral nodal T‐cell lymphoma is considered chemotherapy resistant and carries a relatively poor prognosis. Prospective evaluations reporting the impact of chemotherapy on progression‐free survival (PFS) and overall survival time for dogs with T‐cell lymphoma are lacking. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Musser, Margaret L., Clifford, Craig A., Bergman, Philip J., Treml, Laura S., McAnulty, Lydia C. Cook, McNiel, Elizabeth A., Johannes, Chad M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624070/
https://www.ncbi.nlm.nih.gov/pubmed/36329876
http://dx.doi.org/10.1002/vro2.49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624070/
https://www.ncbi.nlm.nih.gov/pubmed/36329876
http://dx.doi.org/10.1002/vro2.49

Ejemplares similares